Schlaak JF[au] - Search Results

Year	Number of Results
1993	1
1994	5
1995	4
1996	4
1997	9
1998	5
1999	4
2000	5
2001	4
2002	4
2003	3
2004	1
2005	1
2006	1
2007	6
2008	4
2009	5
2010	5
2011	9
2012	11
2013	19
2014	23
2015	10
2016	9
2017	3
2019	1
2020	1
2021	1
2022	2

1

Pattern Recognition Receptors and Liver Failure.

Wu J, Han M, Li J, Yang X, Zhen X, Schlaak JF, Yang D, Lu M. Wu J, et al. Among authors: schlaak jf. Crit Rev Immunol. 2019;39(4):289-311. doi: 10.1615/CritRevImmunol.2019031012. Crit Rev Immunol. 2019. PMID: 32421970 Review.

2

IFN-α subtypes: distinct biological activities in anti-viral therapy.

Gibbert K, Schlaak JF, Yang D, Dittmer U. Gibbert K, et al. Among authors: schlaak jf. Br J Pharmacol. 2013 Mar;168(5):1048-58. doi: 10.1111/bph.12010. Br J Pharmacol. 2013. PMID: 23072338 Free PMC article. Review.

3

Role of Toll-like receptors in liver health and disease.

Broering R, Lu M, Schlaak JF. Broering R, et al. Among authors: schlaak jf. Clin Sci (Lond). 2011 Nov;121(10):415-26. doi: 10.1042/CS20110065. Clin Sci (Lond). 2011. PMID: 21797822 Review.

4

Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation.

Hoyo-Becerra C, Schlaak JF, Hermann DM. Hoyo-Becerra C, et al. Among authors: schlaak jf. Brain Behav Immun. 2014 Nov;42:222-31. doi: 10.1016/j.bbi.2014.06.200. Epub 2014 Jul 24. Brain Behav Immun. 2014. PMID: 25066466 Review.

5

Radioembolization with yttrium-90 glass microspheres for patients with hepatocellular carcinoma: a review.

Schlaak JF. Schlaak JF. Hepat Oncol. 2014 Oct;1(4):387-393. doi: 10.2217/hep.14.20. Epub 2014 Dec 11. Hepat Oncol. 2014. PMID: 30190974 Free PMC article. Review.

6

CCL5: a double-edged sword in host defense against the hepatitis C virus.

Katsounas A, Schlaak JF, Lempicki RA. Katsounas A, et al. Among authors: schlaak jf. Int Rev Immunol. 2011 Oct-Dec;30(5-6):366-78. doi: 10.3109/08830185.2011.593105. Int Rev Immunol. 2011. PMID: 22053974 Review.

7

[When should methotrexate hepatopathy be suspected and which measures are advisable?].

Passens D, Schlaak JF. Passens D, et al. Among authors: schlaak jf. Z Rheumatol. 2022 Feb;81(1):67-70. doi: 10.1007/s00393-021-01136-7. Epub 2021 Dec 3. Z Rheumatol. 2022. PMID: 34860288 German. No abstract available.

8

Hepatitis B Virus Particles Activate Toll-Like Receptor 2 Signaling Initially Upon Infection of Primary Human Hepatocytes.

Zhang Z, Trippler M, Real CI, Werner M, Luo X, Schefczyk S, Kemper T, Anastasiou OE, Ladiges Y, Treckmann J, Paul A, Baba HA, Allweiss L, Dandri M, Gerken G, Wedemeyer H, Schlaak JF, Lu M, Broering R. Zhang Z, et al. Among authors: schlaak jf. Hepatology. 2020 Sep;72(3):829-844. doi: 10.1002/hep.31112. Epub 2020 Jul 11. Hepatology. 2020. PMID: 31925967

9

Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tags.

Megger DA, Rosowski K, Ahrens M, Bracht T, Eisenacher M, Schlaak JF, Weber F, Hoffmann AC, Meyer HE, Baba HA, Sitek B. Megger DA, et al. Among authors: schlaak jf. Biomarkers. 2017 Mar;22(2):113-122. doi: 10.1080/1354750X.2016.1210678. Epub 2016 Jul 28. Biomarkers. 2017. PMID: 27467182

10

A practical data processing workflow for multi-OMICS projects.

Kohl M, Megger DA, Trippler M, Meckel H, Ahrens M, Bracht T, Weber F, Hoffmann AC, Baba HA, Sitek B, Schlaak JF, Meyer HE, Stephan C, Eisenacher M. Kohl M, et al. Among authors: schlaak jf. Biochim Biophys Acta. 2014 Jan;1844(1 Pt A):52-62. doi: 10.1016/j.bbapap.2013.02.029. Epub 2013 Mar 15. Biochim Biophys Acta. 2014. PMID: 23501674 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results